Koers Alterola Biotech, Inc. Other OTC
Aandelen
ABTI
US02152V1035
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 35,27 mln. 32,75 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -6 mln. -5,57 mln. | Nettowinst (verlies) 2023 | -1 mln. -929K | EV/omzet 2022 | - |
Nettoschuld 2022 | 199K 185K | Nettoschuld 2023 | 1,41 mln. 1,31 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-26,2
x | K/w-verhouding 2023 |
-20,2
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 56,4% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Hitchcock
CEO | Chief Executive Officer | 61 | 18-05-22 |
Timothy Rogers
CHM | Chairman | 60 | 21-06-21 |
Colin Stott
COO | Chief Operating Officer | 57 | 21-06-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Hitchcock
CEO | Chief Executive Officer | 61 | 18-05-22 |
Nathan Thompson
BRD | Director/Board Member | - | 10-10-23 |
Daniel Reshef
BRD | Director/Board Member | 73 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,91% | 109 mld. | |
+10,87% | 105 mld. | |
+1,28% | 22,25 mld. | |
-13,14% | 22,09 mld. | |
-7,05% | 18,68 mld. | |
-38,36% | 17,58 mld. | |
-10,66% | 16,85 mld. | |
+3,75% | 13,76 mld. | |
+36,70% | 12,46 mld. |